Divis Laboratories gets no observations after USFDA inspection

22 Feb 2016 Evaluate

Divis Laboratories had a successful inspection by the US-FDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6353.90 -40.75 (-0.64%)
01-Jan-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.65
Dr. Reddys Lab 1253.05
Cipla 1503.00
Zydus Lifesciences 910.20
Lupin 2085.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×